Fig. 4From: Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibodyTissue-to-blood AUC ratio of RG7356 as a function of antibody dose. a Ratios for spleen, liver, bonemarrow, kidney and lung. b Ratio for brain. Data is presented as mean; error bars represent SDBack to article page